AOA Diagnostics

AOA Dx

This biotech firm develops non-invasive liquid biopsy tests to provide healthcare providers with early-stage ovarian cancer diagnostics for their patients.

AOA

This company develops non-invasive liquid biopsy blood tests for the early detection of ovarian cancer for healthcare providers and patients.

Voc Diagnostics

This company develops diagnostic instruments using machine learning and sensor technology to detect ovarian cancer from blood plasma samples for healthcare providers.

20/20 BioLabs

This company develops AI-powered blood tests for the early detection and prevention of cancers and chronic diseases for individuals and healthcare providers.

Abcodia

The company develops biomarker-based blood tests and algorithms for the early detection of ovarian cancer in high-risk women.

Molecular Stethoscope

This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.

Omica

This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.

Oncoliq

This company develops liquid biopsy tests using molecular biology and machine learning for early cancer detection in clinical and screening settings.